Core Viewpoint - Macquarie's research report indicates that Samsonite's revenue for the second quarter decreased by 4.8% year-on-year, with adjusted EBITDA falling by 18.1%, both aligning with the firm's expectations [1] Group 1: Financial Performance - Samsonite's management anticipates an improvement in sales for the third quarter, but weak consumer sentiment continues to create uncertainty regarding future prospects [1] - The firm has adjusted its net profit forecasts for 2025 to 2027 upwards by 2.1%, 3.7%, and 1.8% respectively, reflecting effective cost control measures [1] Group 2: Strategic Responses - To address the impact of tariffs, the company has raised prices in the North American market and plans to adjust prices further based on new tariffs [1] - The company is preemptively procuring inventory for the North American market and negotiating with suppliers to mitigate currency exchange rate impacts [1] - In the medium term, the company aims to control costs through product redesign [1] Group 3: Market Outlook - The target price for Samsonite has been raised from HKD 13.3 to HKD 14, while maintaining a "Neutral" rating, as the company faces ongoing challenges in demand for the second half of the year [1]

Core Viewpoint - China Resources Medical expects a decline in profit attributable to shareholders by 20% to 25% for the six months ending June 30, 2025, primarily due to reduced average medical expenses under the healthcare insurance system and a gradual exit from the IOT (Investment-Operation-Transfer) business [1] Financial Summary - The profit attributable to shareholders is projected to decline by 55% to 60% when excluding a one-time gain of approximately 210 million RMB from the Yan Hua IOT agreement, which includes management fees and compensation for supply chain losses [1] - The main reason for the profit decline is the decrease in operating profit of its medical institutions due to lower average medical expenses [1] Business Strategy - The company plans to optimize its revenue structure, enhance management efficiency, and control costs in the second half of 2025 to improve operational effectiveness [1]